Since the 1980s, attempts at experimental fetal cardiac bypass for the purpose of correcting severe congenital heart defects in the womb have been hampered by deterioration of placental function. This placental pathophysiology in turn affects transplacental transport of nutrients and gas exchange. To date, the effects of bypass on fetal metabolism and oxygen delivery have not been studied. Nine Suffolk sheep fetuses from 109-121 days gestation were instrumented and placed on fetal bypass for 30 minutes and followed post-bypass for 2 hours. Blood gases, glucose and lactate were serially measured in the fetal arterial and umbilical venous circulations throughout the procedure. Insulin and glucagon levels were serially measured by immunoassay in fetal plasma. Fetal-placental hemodynamics were measured continuously. The expression of glycogen content was examined in fetal liver. Oxygen delivery to the fetus and fetal oxygen consumption were significantly deranged after the conduct of bypass (in-group ANOVA p=0.001 and overall contrast p=0.072 with planned contrast p<0.05 for delivery and consumption, respectively). There were significant alterations in fetal glucose metabolism in the postbypass period, however insulin and glucagon levels did not change. Fetal liver glycogen content appeared lower after bypass. This is the first report documenting fetal metabolic dysregulation that occurs in response to the conduct of fetal bypass. The significant alterations in fetal oxygen and glucose delivery coupled with hepatic glycogen depletion complicate and impede fetal recovery. These initial findings warrant further investigation of interventions to restore metabolic and hemodynamic homeostasis after fetal bypass.
Introduction
The advancement of fetal echocardiography allows for early identification of congenital heart defects (42, 52) . There is tantalizing evidence that certain fetal interventions could either prevent defect progression or lessen the severity (20) . A subset of these lesions would benefit from the equivalent clinical armamentarium of cardiac surgery, with extracorporeal bypass support in the fetus (2, 5, 16, 20, 50) . Since the 1980s, experimental studies of fetal cardiac surgery with extracorporeal bypass support have reported variable increases in placental vascular resistance (PVR) and deterioration of gas exchange, which has impeded clinical translation of the technique (5, 9) . Fetal metabolism is greatly dependent on maternal transport of nutrients through the placenta; therefore, understanding how bypass induced placental pathophysiology affects fetal metabolism will have significant implications for successful clinical translation. The metabolic response to hypoxia in the fetus has been well documented; however, we are not aware of any previous reports examining the fetal metabolic response to extracorporeal circulation.
Fetal metabolism at basal levels has been well described in the ovine model (7, 18, 21, 26, 27, 32, 34) . Glucose is transported by the placenta to the fetus via facilitated diffusion carrier proteins: GLUT-1 and GLUT-3 (12, 15) . Placental and fetal uptake are directly related to maternal glucose concentration (22) . The primary metabolic substrates of the fetal hearts are glycolytically derived glucose with uptake regulated by insulin, glucagon and GLUT-1 (17, 37, 40) and lactate by a monocarboxylate co-transporter (3, 36, 51) . The placenta is a rich source of lactate and other substrates such as amino acids (11) , and the fetal liver stores and supplies glycogen. Oxygen transport to the fetus is dependent on the maternal-fetal oxygen gradient, hemoglobin concentration of fetal blood, and umbilical and uterine blood flows (33) .
Oxygen delivery and adequacy of metabolic support are crucial in successful outcomes for pediatric (38, 46) and adult cardiac surgery (47, 48) . Surprisingly, fetal insulin and glucagon concentrations have not been measured in the setting of fetal bypass.
Our laboratory set out to characterize the metabolic response to surgical manipulation and extracorporeal bypass support, as required in fetal cardiac surgery, by examining the delivery, consumption, and extraction of oxygen, glucose, and lactate. We hypothesize that declining umbilical blood flow with concurrent increases of placental vascular resistance (PVR) associated with fetal bypass support leads to 1) decreases in oxygen and glucose deliveries to the fetus, 2) increases of fetal oxygen and glucose consumptions and extractions with corresponding glycogen depletion, 3) increases in fetal production and placental uptake of lactate, and 4) increased levels of fetal insulin and glucagon.
Materials and Methods

Surgical Instrumentation
Nine time-dated singleton and twin pregnant Suffolk ewes from 109 to 121 days of gestation (term ~148 days), with body weight of 70 ± 7 kg, (mean±SD), were used in this study. Ewes were fasted for 24 hours prior to surgery, sedated with ketamine (Wyeth Pharmaceuticals, Fort Dodge IN) and diazepam (Roche Pharmaceuticals, Nutley NJ), and then intubated endotracheally with maintenance anesthesia of 2% inhaled isoflurane and 98% oxygen. The fetuses were not directly treated with any analgesia or anesthesia; however, transplacental delivery of maternally inhaled isoflurane was relied upon for anesthesia, as in clinical fetal surgery. Further, steroids and inotropic support were not administered to the mother or fetus during this experimental protocol. Catheters were placed in the maternal femoral artery and vein for blood gas sampling and IV fluid support. A midline laparotomy followed by minimal hysterotomy was used to access the fetal hind limb to catheterize the fetal femoral artery (advanced to distal aorta) for blood gas & arterial pressure measurements. Through the same hysterotomy, an umbilical vein catheter is placed for placental blood gas and metabolic measurements, and advance to the common umbilical vein. Subsequently, a 4 or 6mm Doppler flow probe (Transonic Systems, Ithaca NY) was placed on the common umbilical artery via a retro-peritoneal approach to measure umbilical blood flow. The fetal and maternal incisions were closed in layers and a minimum seven-day recovery period ensued during which time hemodynamic values were monitored daily using a PowerLab data acquisition system (AD Instruments, Colorado Springs CO). Thus animals were pre-instrumented and not acutely undergoing the fetal cardiac bypass protocol. All procedures were performed in accordance with Institutional Animal Care and Use Committee (IACUC) procedures in an Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) approved facility.
Fetal Bypass Support
Using previously described methods (2, 14, 24, 31), fetal bypass was performed after right jugular vein cannulation using a 10 or 12F Bio-Medicus cannula (Medtronic, Minneapolis, MN), and right carotid artery cannulation using a 6 or 8F Bio-Medicus cannula, a safer approach with regards to mid-gestation fetal heart size and tissue strength. Fetal sternotomy was performed to simulate clinical cardiac surgical methodology and to ensure the proper location of cannula tips for optimal fetal bypass perfusion support.
The pump system was normothermic and non-pulsatile, consisting of a commercial clinical roller pump with vacuum-assisted venous drainage and in-line heat exchanger. The placenta was the sole oxygenator (16) and was not sequestered from the bypass support circuit. The bypass circuit was filled with nonmaternal adult ewe whole blood collected no more than 24 hours prior to the experiment, in Citrate Phosphate Dextrose Adenine (CPDA-1) blood bags (Pall Corporation, East Hills, NY) containing 2.0 grams of dextrose per bag. Blood bags, if kept overnight, were stored at 4°C with gentle orbital agitation to preserve anticoagulation. Upon addition to the bypass support circuit the blood was pH adjusted with sodium bicarbonate (Hospira Inc., Lake Forest IL) and with mannitol (Hospira Inc.). Mannitol is routinely added in the clinical setting as an osmotic agent and as a potential anti-oxidant. No additional glucose or steroids were added to the prime. The fetus was anticoagulated with 300 Units  kg -1 of heparin (APP Pharmaceuticals, Schaumburg IL) prior to initiation of bypass.
Fetuses were placed on bypass support for 30 minutes and then observed for 2 hours after termination of bypass. Previous studies have shown that the target bypass flow rate reaches 200 mL  min -1  kg -1 , using fetal normograms for assumed fetal weight (31). In these experiments, the fetal heart was not arrested and contributed a small amount to the total fetal systemic perfusion during bypass. Due to the unusual venous anatomy of the sheep (e.g. left azygous continuation to the coronary sinus) there is incomplete emptying of the fetal heart during bypass. After completion of experimental protocol, maternal ewe and fetus were euthanized using Fatal Plus (Vortech Pharmaceutical, Dearborn MI) for autopsy, measurement of fetal weight, and confirmation of catheter positions.
Sampling Regimen
Maternal and fetal blood samples were collected in the conscious state (prior to anesthesia), after anesthesia (stabile, prior to surgery), at completion of maternal hysterotomy, after fetal heart cannulation, 
Insulin and Glucagon immunoassays
Fetal blood samples for hormone immunoassay were collected in the conscious state at completion of hysterotomy, after fetal heart cannulation (immediately prior to bypass onset), at 30 minutes of fetal bypass, and at 30 and 120 minutes after bypass. Blood samples were collected into lithium heparin coated tubes (Monovettes, Sarstedt, Newton, NC), immediately placed on ice, centrifuged and the separated plasma then frozen at -20°C until assay. The insulin levels in fetal plasma were determined using an ovine specific ELISA assay from ALPCO Diagnostics (Salem, NH) with a sensitivity of 0.14 ng/ml. Glucagon levels in fetal plasma were measured using a colorimetric ELISA assay from Phoenix Pharmaceuticals (Burlingame, CA) with a sensitivity of 0.10 ng/ml.
Fetal Glycogen Histochemistry
The expression of glycogen levels in fetal liver was determined in samples collected 120 minutes after fetal bypass and compared to a group of six fetal liver specimens from uninstrumented controls using routine tissue collection methods. Frozen fetal liver sections (8 micron) were stained for glycogen with a standard Periodic acid-Schiff's technique, which uses a histological reaction to generate colorimetric assessment of glycogen content.
Metabolic Calculations and Statistical Analysis
The umbilical vein is considered the delivery conduit of substrates (oxygen and glucose) to the fetus. To determine differences in measured parameters, the data is analyzed with Type III ANOVA for in-group differences. One-way analysis of variance (ANOVA) tests for in-group differences and for 
Results
Maternal Hemodynamic and Blood Gases
Under general anesthesia maternal ewes maintained steady levels of arterial pH, pCO 2 , glucose, lactate, mean arterial pressure and heart rate. Maternal pO 2 & SO 2 levels, however, rose to approximately 400 mmHg and 100% saturation, respectively, as anticipated.
Fetal Hemodynamics and Blood Gases
Fetal arterial pH declined over the course of the experiment, being most pronounced in the postbypass period (post hoc p≤0.002 for all; Table 1 ) and manifest as mixed acidosis with concurrent elevations of pCO 2 and lactate (in-group ANOVA p≤0.002 for both; Table 1 ). The trend toward hypercapnia was first notable during bypass and became most apparent at 30 minutes post-bypass.
Elevation of fetal lactate was pronounced in the post-bypass period, however fetal glucose remained stable throughout (Table 1) , similar to glucose levels in prior sham controls (p=0.264, n=10). From a hemodynamic standpoint, as expected and as reported by us previously, there is a slight but significant decrease in fetal MAP with anesthesia induction (Table 2) . Fetal heart rate, however, did not alter with the conduct of experiment. More importantly, umbilical blood flow declined nearly 50% from baseline levels prior to the initiation of bypass support (in-group ANOVA p=0.01, Table 2 ). Umbilical blood flows were temporarily elevated during bypass support but declined significantly after cessation of bypass (post hoc p≤0.017 for all, Table 2 ). The mean bypass pump flows were 183 mL · min -1 · kg -1 and 175 mL · min -1 · kg -1 at 15 and 30 minutes of bypass support, respectively. Despite decreasing umbilical flows, placental vascular resistance remained steady (in-group ANOVA p=0.642, Table 2) , showing an increase only at 120 minutes post-bypass (p=0.046, Table 2 ).
Delivery, Consumption, and Extraction
Oxygen
Fetal oxygen metabolism was profoundly disrupted by fetal surgery and bypass. There was a precipitous drop in oxygen delivery to the fetus before and after bypass ( Fig.1 Table 3 ). Fetal oxygen extraction continually declined from ~60% at baseline until 30 minutes of bypass (contrast p=0.021, Fig. 1 crossed circles; Table 3 ) before rebounding over baseline in the post-bypass period (in-group ANOVA p=0.068; Table 3 ). Anesthesia, surgery and fetal bypass did not alter maternal, fetal or umbilical oxygen contents (Table 4a) , and those three vascular beds each maintained different oxygen content levels (ANOVA and post hoc p-values = 0.0009 for all pair-wise comparisons versus baseline, Table 4a ).
Glucose
Fetal glucose delivery was stable until it declined at 90 and 120 minutes post-bypass (Table 3) .
Fetal glucose consumption varied over the course of the procedure from -1 to 5 mg ·min -1 · kg -1 and peaked at 60 minutes during the post-bypass period before dramatically falling (Table 3 ). Fetal glucose extraction followed the trend of fetal glucose consumption, falling and later rising in a concordant manner (Table 3) , possibly reflecting the late declines in glucose delivery. Bypass support did not significantly alter fetal glucose content (Table 4b ). Maternal arterial glucose content was significantly higher than fetal arterial and umbilical vein content (post hoc p=0.0009 for both, Table 4b ); in contrast, fetal arterial glucose was not different from umbilical vein content (Table 4b) .
Lactate
There was a profound and sustained increase in fetal lactate production (~75%) over the course of the bypass protocol (Table 3) . Placental lactate uptake declined during bypass support and fell nearly 70% below baseline levels in the post-bypass period (Table 3) . Lactate extraction fell concurrently from baseline; mimicking the decline in placental uptake (Table 3) . Fetal lactate content (mmoL · L -1 ) was significantly elevated after the conduct of bypass (ANOVA for type of vascular bed and time of sampling p=0.008, Table 4c ). Maternal arterial lactate content was significantly lower compared to fetal arterial and umbilical vein contents (LSD Post Hoc p=0.0009 for both, Table 4c ). Fetal arterial lactate content when analyzed without regard to sampling time was not different than umbilical vein (post hoc p=0.247; Table   4c ).
Hemodynamic Correlations
There was a strong negative correlation for PVR and oxygen delivery (R 2 =0.86,) indicating that increases in PVR correlated with decreases in oxygen delivery. There was also a strong positive correlation between umbilical blood flow and oxygen delivery to the fetus (R 2 =0.82,) indicating that increases in umbilical flow were tightly matched with increased oxygen delivery to the fetus.
Metabolic Regulatory Hormones in Fetal Plasma
Fetal insulin levels did not change over the protocol (in-group ANOVA p=0.497, Figure 2A ), but tended to rise during bypass, (post hoc p = 0.07). Similarly, fetal glucagon levels also remained stable (ingroup ANOVA p=0.170, Figure 2B) ; by 120 minutes after bypass, however, glucagon levels trended towards elevation ( Figure 2B , post hoc p=0.08).
Glycogen Expression in Fetal Liver
There was a dramatic decrease in fetal liver glycogen expression by 120 minutes after bypass when compared to uninstrumented controls ( Figures 3A and B , respectively).
Discussion
Changes in fetal blood levels of oxygen, glucose and lactate with fetal bypass have been previously described (5, 6, 9, 16, 29-31, 45, 49) . However, this is the first report documenting the dramatic shifts in oxygen and glucose delivery, consumption and extraction that occur with the conduct of fetal anesthesia, surgery and cardiac bypass. Our study shows concurrent declines in fetal oxygen delivery, consumption and extraction with fetal anesthesia and surgery prior to bypass followed by increased extraction in the post-bypass period when fetal oxygen delivery falls below 40% of baseline.
Fetal glucose delivery, consumption and extraction also decline in the pre-bypass period, then consumption and extraction rebound in the early post-bypass period before falling precipitously, likely due to stress, gluconeogenesis and dysregulation. Interestingly, fetal insulin and glucagon levels did not change, perhaps due to the observed depletion of fetal hepatic glycogen reserves. Profound and durable lactate production throughout the post-bypass period abrogates consumption and extraction, and likely contributes to metabolic disruption. These findings suggest that optimizing fetal hemodynamics and tissue oxygen delivery post bypass and suppressing or removing excess lactate are necessary steps to resuscitate the fetus after bypass, and might have significant implications for clinical translation of fetal cardiac surgery.
Adequate oxygen delivery to meet tissue demands is one of the most critical factors in affecting serum lactate levels. In the fetus oxygen delivery is dependent on umbilical flow which is driven by fetal cardiac output (19) and regulated by placental vascular resistance. Basal levels of oxygen delivery to the sheep fetus are typically greater than 20 mL · min -1 · kg -1 , with a reported minimum of 14 mL · min -1 · kg -1 required for aerobic metabolism (13) . In our studies, oxygen delivery to the fetus declined over the course of fetal surgery, reaching 50% of basal levels in the late post-bypass period, similar to the declines observed for fetal cardiac output (5, 16), and placental blood flow (2, 5, 16) . Early declines in these parameters are explained in part by general anesthesia and the maternal ewes being placed in the supine position. However, normative oxygen delivery was restored during bypass support before again slipping below the purported threshold for aerobic metabolism and declining throughout the post-bypass period.
This decrease, most significant at 120 minutes post-bypass, had a strong negative correlation to PVR and, as expected a strong positive correlation to umbilical blood flows. Increasing PVR after fetal bypass has been described (5, 9, 16, 49) and is currently attributed in part to disruption of the nitric oxide pathway in the placental vasculature, as we and others have shown (5, 8, 29, 49, 50) . In this study, as in prior studies (2, 24, 30), we did not observe a significant rise in PVR but did observe declines in umbilical blood flow and fetal mean arterial pressure suggesting there is some cardiogenic component to the observed hemodynamic declines. These results together suggest the importance of optimizing fetal cardiac output post bypass.
We showed that fetal oxygen consumption matched the preceding decreases in oxygen delivery during the pre-bypass period yet fetuses maintained a steady state of oxygen extraction, indicative of the large protective oxygen reserve that exists across the uterine-umbilical circulation (27) . In contrast, there was a doubling of oxygen extraction during the post-bypass period as fetal oxygen delivery and consumption further decreased below 30 to 60% of the previously reported fetal basal oxygen consumption of 7 mL · min -1 · kg 1 (13) . Similarly, prior investigations using models such as umbilical occlusion or induction of maternal hypoxia which acutely reduce oxygen delivery and consumption by 50% or more also generated increased oxygen extraction (26, 34) , indicating that profound changes in oxygen delivery and consumption are necessary to augment extraction. Furthermore, umbilical venous oxygen contents remained relatively stable in our model and the aforementioned acute models. This suggests that the fetus will first reduce consumption in the face of acute stress until the severity of the insult exceeds the normally large fetal oxygen reserve and necessitates the augmentation of oxygen extraction. The explanation for this seemingly paradoxical response may be due in part to the unique redistribution of fetal circulation following fetal bypass (5, 39) . With redistribution there is preferential shunting of blood away from some fetal organs (including placenta) to the brain, heart, and the adrenals, the so-called "brain-sparing" or "fetal hypoxia" effect. This regional shunting ensures adequate oxygen delivery to more 'important' organ systems during decreases in oxygen availability. In this study there was no manipulation of the uterine vasculature aside from the aforementioned postural and anesthetic effects on uterine blood flows (14) which in turn affect oxygen transfer across the placenta, particularly at rate limiting uterine blood flows. Increases in umbilical to uterine blood flow ratios would equate to decreases in umbilical oxygen content (19, 27) suggesting that both uterine and umbilical flows would need to be simultaneous and proportionally elevated for optimal fetal perfusion. Together with our prior work showing poor correlation between maternal hemodynamics and uterine blood flow during fetal cardiac surgery (14) , these findings support the importance of ensuring ample uterine blood flow through appropriate maternal inotropic/vasoactive therapy to ensure adequate oxygen delivery to the fetus during periods of limited or decreased umbilical flows post bypass.
The transfer of oxygen across the placenta could be affected by alterations in fetal blood content during and after bypass. The bypass pump circuit is primed with adult donor blood (~300 mL) and thus the fetal circulation is diluted by ~50% with adult hemoglobin which might reduce oxygen carrying capacity in the fetal circulation. This potential effect is of greater significance in the ovine model where there is a large difference between the adult and fetal P 50 . Adult sheep hemoglobin P 50 is ~ 34 mmHg;
while, the ovine fetal P 50 is ~ 17 mmHg (a net difference of 17 mmHg). Of note, total exchange transfusion with adult blood in the fetal ovine model has been reported to result in umbilical blood flows declining by ~37% from pre-transfusion levels while maintaining fetal blood pressures (25), suggesting that significant transfusions of the fetus with adult hemoglobin might also cause a relative increase in PVR. Importantly, the human maternal-fetal P 50 difference is only ~4 mmHg (10, 44) , suggesting the use of adult donor blood in the clinical setting may be less problematic in this respect, particularly since clinical use of fetal prime blood is not an option. Therefore, based on our findings, we believe that methods that can preserve fetal hemoglobin or favorably modify the adult hemoglobin binding curve (e.g., removing 2,3 diphosphoglycerate) to one more similar to fetal hemoglobin could be advantageous.
Glucose and lactate are key substrates for fetal and placental metabolism. Glucose delivery is regulated by facilitated diffusion across the placenta (12, 15) . We report a substantial decline (>60%) in glucose delivery to the fetus in the post-bypass period and declining umbilical blood flows and oxygen delivery. This result coupled with our observation that fetal insulin and glucagon levels are stable throughout the bypass and post-bypass period suggests the fetus is actively modulating endogenous sources of glucose. Furthermore, these results are consistent with studies showing the stressed fetus will preferentially use endogenous energy supplies, even with abundant exogenous substrates, a process largely regulated by fetal insulin and glucagon (21, 32) .
Under stress the fetus can carry out metabolism via glycogenolysis, mainly from the liver, and via gluconeogenesis. The fetus however, has a limited ability for gluconeogenesis (1, 4, 23, 28) . We also report a profound depletion in fetal hepatic glycogen two hours after bypass when compared to baseline controls, consistent with a prior fetal bypass study that examined hepatic glycogen content thirty minutes after bypass (45) . Considering the context of time, this suggests the fetus likely relies on glycogenolysis in response to the stress of fetal surgery and bypass to support and sustain its increased need for glucose.
Of note, cortisol, catecholamines (e.g. epinephrine) and vasopressin that are elevated with fetal bypass (30, 45) , can also stimulate glycogenolysis and gluconeogenesis, indicating numerous factors play a role in regulating and sustaining fetal metabolism after the stress of fetal cardiac surgery with bypass.
Not surprisingly, fetal glucose consumption as measured decreases to nearly zero in the late postbypass period, largely because delivery declines via reduced blood flows and endogenous substrates and coincident soaring lactate levels. Glucose content of the umbilical venous circulation exceeds that of the fetal arterial circulation throughout our study indicating that facilitated diffusion remains operational to some degree. Thus, exogenous fetal glucose administration would not likely benefit the fetus and would more likely be harmful by contributing to further acidosis through lactate production. Fetal insulin and glucagon levels remained stable suggesting future studies looking at these modulators may not be particularly informative when assessing fetal glucose consumption and regulation during in-utero interventions. The results suggest, however, that if one can selectively manipulate or decrease fetal metabolism during surgery, it would result in a salutary response from the fetus. In standard cardiac surgery, use of hypothermia is the typical tool implemented to accomplish this goal. Since hypothermia has untoward effect on the placenta, however, alternative, perhaps more innovative approaches need to be designed to impact this parameter.
Fetal anesthesia could blunt or prevent the fetal stress response which seems to be partly responsible for this metabolic conversion. Prior fetal bypass studies have used steroid administration to combat the fetal stress response. The steroids, however, can also increase glucose levels and hence adversely effect the metabolic response (16) . Interestingly, Carotti et al. observed that methylprednisolone administration prior to fetal bypass lowers fetal glucose values compared to controls; however, this therapy did not prevent metabolic acidosis as intended (6) . Our group and others have reported that high dose opiate-based fetal anesthesia (e.g., fentanyl), comparable to clinical practice of cardiac surgery, is actually detrimental to the fetus (41, 43). These findings highlight the importance of further studies on management of the fetal stress response and optimal anesthetic regimen for the fetus.
We report a dramatic rise in fetal lactate production simultaneous with a decline in oxygen delivery, likely related to the conversion from aerobic to anaerobic metabolism. At baseline, the fetus is actually not producing; but, rather using lactate as a substrate. With surgical manipulation the scenario is reversed. The main route of lactate consumption by the fetus is lactate oxidation and synthesis of nonessential amino acids and lipids in the liver (7, 18) . The fetus is known to have a very limited ability for gluconeogenesis using lactate; in contrast, the fetal myocardium will preferentially use lactate for energy (51) . The limited ability of the fetus and placenta to eliminate lactate is compounded with stresses such as fetal bypass that can increase anaerobic metabolism resulting in profound acidosis. We believe that management of oxygen delivery and uptake to the fetus can ameliorate this rise in lactate. The use of artificial measures such as modified ultra-filtration to remove lactate and therefore reduce the associated sequelae of acidosis (6), however, would not treat the underlying problem of inadequate oxygen delivery.
A limitation of our study is our inability to determine whether the fetus is using endogenous or exogenous energy substrates, such as glucose and lactate. Additionally, we can not answer if/when changes in type of substrate usage occur over the course of the procedure. In future studies, the use of radioactively tagged energy substrates is a possibility to refine the understanding of fetal metabolism. We could not measure glucagon or insulin levels in our prior sham bypass fetuses because those samples were consumed in previous studies (24, 29, 30) . Although these hormones did not change with the additional stress of bypass, we cannot rule out the possibility they might change with sham bypass. Similarly, we do not have liver samples from prior sham bypass fetuses in which to examine glycogen; however fetal glucose levels also remained stable in shams, suggesting such data may be of limited value. The glucose analyzer in this study might not have been sensitive enough (precision ±2.5 mg · dL -1 ) to detect the net differences between fetal arterial and umbilical vein glucose values. This lack of sensitivity could have impacted the calculated parameters of glucose delivery, consumption, and extraction. Fetal arterial, umbilical and maternal glucose content values , however, were all significantly different at each timepoint. Finally, we did not measure individual organ perfusion and the respective metabolic responses to fetal bypass which would potentially define regional changes in metabolism.
In conclusion, fetal cardiac surgery and extracorporeal circulation dramatically alter the fetal metabolic response. Of the parameters examined in this study, oxygen was the most profoundly affected.
These changes will have to be taken into account for successful clinical translation. Simple interventions that increase oxygen delivery (e.g., increasing cardiac output, reducing fetal hemoglobin dilution), reduce lactate build-up (e.g. continuous ultrafilitration) or further decrease oxygen consumption (e.g., using paralytic agents) should result in improved outcomes.
Perspectives and Significance
Despite impressive medical and surgical advances, certain complex congenital heart defects (e.g., hypoplastic left heart syndrome with intact atrial septum) continue to have significant associated mortality and morbidity either in utero or shortly after birth. This is in part due to injury that has occurred before birth because of altered intra-cardiac blood flow patterns. Fetal cardiac surgery, alongside other evolving fetal cardiac interventions, holds the promise of improving outcomes for patients with severe heart defects. However, the acute stress of fetal surgery with cardiac bypass reduces systemic and placental blood flows while simultaneously increasing fetal oxygen and glucose metabolism. These sequelae further compromise metabolic waste removal which could in turn lead to greater placental dysfunction and hence, poor outcomes. Further understanding and the development of strategies that can improve fetal circulation, particularly fetal cardiac output, could enhance nutrient availability and metabolic efficiency, and should be helpful for clinical translation of fetal cardiac surgery.
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We have no conflicts of interest to report for this study. . The x-axis indicates specific time points of experimental protocol for the values reported, with (BL) indicating baseline or pre-fetal heart cannulation. There were significant changes in oxygen delivery throughout the protocol, p<0.01. Note the temporary restoration of oxygen delivery during bypass (p=0.032) followed by the profound concurrent loss of delivery and reduced oxygen consumption in the late post-bypass period, (p<0.05 for both). Oxygen extraction initially declines by 40% from baseline; however note that the post-bypass period is also marked by steadily increasing oxygen extraction that eventually supersedes baseline values as the fetus compensates for the corresponding reductions in oxygen delivery. Data are n=8 fetuses for each mean value. Neither insulin nor glucagon changed over the course of fetal bypass, both in-group ANOVA greater than p=0.05. The observed stability of these hormones throughout the protocol indicates a relatively functional metabolic regulatory mechanism in the fetus that is capable of using available glucose and glycogen stores for fuel during extended periods of acute stress such as fetal surgery. Data are n=6 fetuses for each mean value with standard deviation. 
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